Home / About Us / News and Resources / Insights Newsletter

Insights Enterprise Newsletter

Insights Enterprise Newsletter
Insights Newsletter: When to Give COVID-19 Boosters, What is Delta-8 THC, New CE for November, and More!

Clinical pharmacy leadership updates including improving access to buprenorphine for opioid use disorder, new training products, and more.

Read More
Insights Enterprise Newsletter
Insights Newsletter: Flu Vaccines in 2021-2022, Acquisition of Bula Intelligence, New CE for October, and More!

Clinical pharmacy leadership updates including improving access to buprenorphine for opioid use disorder, new training products, and more.

Read More
Insights Enterprise Newsletter
Insights Newsletter: First Med for COVID-19 Post-Exposure Prophylaxis, New CE for September, and More!

Clinical pharmacy leadership updates including improving access to buprenorphine for opioid use disorder, new training products, and more.

Read More
Insights Enterprise Newsletter
Insights for: Why Aduhelm Isn’t a Miracle for Alzheimer’s, Latest COVID-19 Resources, New CE for August, and more!

Clinical pharmacy leadership updates including improving access to buprenorphine for opioid use disorder, new training products, and more.

Read More
Insights Enterprise Newsletter
Insights for: Watch for Unexpected Ingredients in New Zantac Products, Latest COVID-19 Resources, New CE for July, and more!

Clinical pharmacy leadership updates including improving access to buprenorphine for opioid use disorder, new training products, and more.

Read More
Insights Enterprise Newsletter
Insights for: Buprenorphine for Opioid Use Disorder, New Training Products, Latest COVID-19 Resources, New CE for June, and more

Clinical pharmacy leadership updates including improving access to buprenorphine for opioid use disorder, new training products, and more.

Read More
Insights Enterprise Newsletter
Insights for: Benzodiazepines, Monoclonal Antibodies for COVID-19, Technicians to Give Vaccines, and more

Clinical pharmacy leadership updates including safe use of benzodiazepines, monoclonal antibodies for COVID-19, and more.

Read More
Insights Enterprise Newsletter
Insights for: Hazardous Med Policy Changes, PPE Skin Irritation, and New CE

Get updates on the latest trends in clinical leadership. In this issue, get practical recommendations for hazardous med policy changes, PPE skin irritation, new CE, an

Read More
Insights Enterprise Newsletter
Insights for: COVID-19, Safe Use of Ketamine, and Hospital/ICU-Specific Resources

Get updates on the latest trends in clinical leadership. In this issue, get practical recommendations for COVID-19 meds and supplements, safe use of ketamine, and hospital/ICU-specific resources for pharmacists.

Read More
Insights Enterprise Newsletter
Insights for: COVID-19, Med Errors During Transitions of Care, and PTU Elite: CSPT® Prep Program

Get updates on the latest trends in clinical leadership. In this issue, get recommendations for COVID-19 infection control, med errors during transitions of care to outside facilities, and new PTU Elite: CSPT Prep Program.

Read More